LAB
NEWS
December
2000 . . . . . . . . . . Vol. 40 No. 1
Chairman:
Peter Jatlow, MD
Editor: Edward L. Snyder, MD
Production Assistant: Marilyn Moran
Contributors:
Li Chai, MD;Richard K. Donabedian, MD; Stephen Edberg, PhD, ABMM;
Barbara Kinder; MD; Marie Louise Landry; Gregory Pomper, MD; Brian
R. Smith, MD; Richard Torres; MD; Sanjivi Wadhwa; Marissa Wilck, MD
Shiga
Toxin Detection in Stool
Shiga
toxin producing Escherichia coli (STEC) have been identified as
the major cause of bloody diarrhea and life-threatening Hemolytic
Uremic Syndrome (HUS).
STEC-associated
HUS predominantly afflicts children under the age of 5 and is a
leading cause of acute renal failure in this age group. Mortality
is reported to be between 2-7% and there is a significant risk of
residual organ damage. In persons above 65 years, the incidence
of hemorrhagic colitis is greatest and the mortality is between
15-23%. STEC has also been recognized as an important cause of common
watery diarrhea (i.e. gastroenteritis).
E
coli 0157:H7 is the most commonly implicated serotype, but infections
involving non 0157 serotypes are increasingly common. The infectious
dose is very low (in the order of 100 bacteria) and outbreaks have
been linked to contaminated food, particularly undercooked ground
beef (hamburgers) and unpasteurized milk, and recently to a contaminated
community water supply. Contaminated drinking and swimming water,
including chlorinated swimming pools, plus lakes and ocean water,
have also been linked to outbreaks. Person-to-person fecal-oral
transmission is common and is the predominant route of infection
in daycare facilities. The organism has also been isolated in farm
animals where healthy cattle act as the primary reservoir. During
food processing, the bacteria are effectively distributed in a large
lot of product.
The
major virulence factor for E.coli 0157 and other serotypes, is the
production of one or more Shiga toxins, also known as verocytotoxins.
Shiga toxin1 is indistinguishable from the shiga toxin produced
by Shigella dysenteriae type 1, while type 2 is a more divergent
molecule. Both toxins consist of five B subunits and a single A
subunit and are encoded on a temperate bacteriophage inserted into
the E.coli chromosome.
E.coli
0157, the first of the STEC E. coli to be involved in outbreaks,
is unique in the E.coli family in its lack of fermentation of sorbitol.
Commercially prepared sorbitol agars, that display pH mediated color
changes with sorbitol fermentation, form the basis of our current
diagnosis in the microbiology lab. The laboratory technologist looks
for sortibol-negative E. coli, and then chooses these colonies for
specific identification. The disadvantage of this method is that
any other organism or E.coli serotypes, that may indeed produce
a shiga toxin, will not be identified. Culture technique requires
between 24 and 48 hours, only detects E.coli 0157, and does not
assay for the toxin itself.
A
new, reliable and rapid test for the detection of shiga toxin 1
and 2 is now available. The Shiga Toxin E. coli (STEC) Microplate
Assay is an enzyme immunoassay which allows direct detection of
the two shiga toxins in stool specimens. The basic outline of the
test is: Rabbit polyclonal anti-Shiga toxin 1 and 2 antibodies are
bound to microplate wells to which diluted specimens is added. After
incubation the enzyme conjugate (monoclonal mouse anti-Shiga Toxins
1 and 2 labeled with horseradish peroxidase enzyme) is added. The
second incubation period is followed by an addition of enzyme substrate
and then visual or spectrophotometric color detection.
The
test is best done on fresh stool specimens because toxin degradation
occurs after several hours. Evaluation of this test was performed
at sites in the United States, Canada and Germany. It was compared
to a cytotoxin assay and all positive or discrepant results were
confirmed by PCR. The summation surveys confirmed a sensitivity
of 87% and a specificity of 96.6%. The negative predictive value
was constantly above 99% in all surveys. The Shiga Toxin E.coli
(STEC) Microplate Assay detects a lower limit of 52pg/ml and 126pg/ml
of shiga toxins 1 and 2 respectively. Because HUS is a clinical
syndrome, the detection of STEC does not mean systemic disease.
Also a correlation between the amount of toxin and the clinical
presentation has not been established. This direct toxin test will
replace our sorbitol agar method, which had required overnight incubation
and subsequent confirmation. The Clinical Microbiology laboratory
will perform this test routinely on all stool specimens. The test
will be performed Monday through Friday with same day results, provided
specimens reach the lab by noon. On other days, please call the
Clinical Microbiology Laboratory, at 688-2460 or the Laboratory
Medicine Resident.
Sanjivi
Wadhwa, M.D.
Marissa Wilck, M.D.
Stephen Edberg, Ph.D., A.B.M.M.
References:
1.
Karch H, Brelaszewska M, Brizon M, Schmidt. Epidemiology and Diagnosis
of Shiga Toxin-Producing Escherichia coli Infections. Diagn Microbiol
Infect Dis 1999; 34: 229-243.
2.
Mead P, Griffin P. Escherichia coli 0157:H7. The Lancet 1998; 352:
1207-1212 Alexon-Trend ProspecT Shiga Toxin E.coli (STEC) Microplate
Assay , Package insert. |